2008
DOI: 10.1016/j.clinbiochem.2008.02.017
|View full text |Cite
|
Sign up to set email alerts
|

A decade of HPLC–MS/MS in the routine clinical laboratory — Goals for further developments

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
99
1
4

Year Published

2009
2009
2015
2015

Publication Types

Select...
5
5

Relationship

1
9

Authors

Journals

citations
Cited by 192 publications
(105 citation statements)
references
References 83 publications
1
99
1
4
Order By: Relevance
“…High analytical specificity, simple sample preparation, and high throughput are typical strengths of LC-MS/MS technology used for therapeutic drug monitoring (13). High analytical precision is, however, not a strength of this technology.…”
Section: Discussionmentioning
confidence: 99%
“…High analytical specificity, simple sample preparation, and high throughput are typical strengths of LC-MS/MS technology used for therapeutic drug monitoring (13). High analytical precision is, however, not a strength of this technology.…”
Section: Discussionmentioning
confidence: 99%
“…However the widespread application of this technology requires substantial further development until it can be used as a routine instrument in the setting of clinical laboratories (Vogeser and Seger, 2008). High-level reference method protocols should be developed through inter-laboratory collaboration (Thienpont et al, 2008).…”
Section: A N U S C R I P Tmentioning
confidence: 99%
“…For TDM purposes, LC-MS/MS has been regarded as technically superior over immunoassays and UV based HPLC/UV methods because of its better specificity and sensitivity, lack of interference or matrix effects [18].…”
Section: Introductionmentioning
confidence: 99%